Abstract | BACKGROUND: CASE PRESENTATION: CONCLUSIONS: Although primary intestinal lymphangiectasia is usually adequately managed by nutritional therapy, complications such as anemia can occur and can prove to be a therapeutic challenge.
|
Authors | Vasile Daniel Balaban, Alina Popp, Mugur Grasu, Florina Vasilescu, Mariana Jinga |
Journal | Journal of gastrointestinal and liver diseases : JGLD
(J Gastrointestin Liver Dis)
Vol. 24
Issue 3
Pg. 369-73
(Sep 2015)
ISSN: 1842-1121 [Electronic] Romania |
PMID | 26405709
(Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antifibrinolytic Agents
- Triglycerides
- Octreotide
|
Topics |
- Anemia
(blood, diagnosis, etiology, therapy)
- Antifibrinolytic Agents
(therapeutic use)
- Biopsy
- Chronic Disease
- Diet, Fat-Restricted
- Dietary Supplements
- Digestive System Surgical Procedures
- Embolization, Therapeutic
- Endoscopy, Gastrointestinal
- Humans
- Lymphangiectasis, Intestinal
(complications, diagnosis, therapy)
- Lymphedema
(complications, diagnosis, therapy)
- Male
- Octreotide
(therapeutic use)
- Protein-Losing Enteropathies
(etiology, therapy)
- Severity of Illness Index
- Treatment Outcome
- Triglycerides
(administration & dosage)
- Young Adult
|